Title |
Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity
|
---|---|
Published in |
Frontiers in immunology, February 2018
|
DOI | 10.3389/fimmu.2018.00314 |
Pubmed ID | |
Authors |
Shingo Kato, Jay A. Berzofsky, Masaki Terabe |
Abstract |
Natural killer T (NKT) cells are a unique T cell subset that exhibits characteristics from both the innate immune cells and T cells. There are at least two subsets of NKT cells, type I and type II. These two subsets of NKT cells have opposite functions in antitumor immunity. Type I NKT cells usually enhance and type II NKT cells suppress antitumor immunity. In addition, these two subsets of NKT cells cross-regulate each other. In this review, we mainly focus on immunosuppressive NKT cells, type II NKT cells. After summarizing their definition, experimental tools to study them, and subsets of them, we will discuss possible therapeutic applications of type II NKT cell pathway targeted therapies. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 6 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 83% |
Scientists | 1 | 17% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 52 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 23% |
Student > Ph. D. Student | 8 | 15% |
Student > Doctoral Student | 3 | 6% |
Other | 3 | 6% |
Student > Master | 3 | 6% |
Other | 6 | 12% |
Unknown | 17 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Immunology and Microbiology | 12 | 23% |
Medicine and Dentistry | 6 | 12% |
Agricultural and Biological Sciences | 6 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Neuroscience | 2 | 4% |
Other | 5 | 10% |
Unknown | 19 | 37% |